SCHEMBL20095958

SCHEMBL20095958

CN(C)Cc1ccc(Br)c(C#N)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ TAAR1 Q96RJ0 2/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ MAOB P27338 2/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ PRKACA P17612 1/20 0.34
▸ PRKACG P22612 1/20 0.34
▸ PRKACB P22694 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ NOS3 P29474 1/20 0.34
▸ NOS1 P29475 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17194382 0.86 HRH3 (0.41) HRH3ALDH1A1TSHRTAAR1CYP19A1
SCHEMBL15716128 0.81 MAOB (0.39) ALDH1A1TSHRCYP19A1MAOBCYP1A2
SCHEMBL19682405 0.79 CYP2A6 (0.47) ALDH1A1TSHRMAOBCYP1A2CYP2D6
SCHEMBL18006944 0.79 PYCR1 (0.46) HRH3ALDH1A1TAAR1CYP19A1HTR7
SCHEMBL30762181 0.77 CYP1A2 (0.41) HRH3ALDH1A1TSHRCYP19A1CYP1A2
SCHEMBL29278121 0.77 CYP1A2 (0.41) HRH3ALDH1A1TSHRCYP19A1CYP1A2
SCHEMBL20095630 0.76 LOXL2 (0.50) TAAR1MAOBHTR7MAOANOS1
SCHEMBL24197155 0.76 SRC (0.39) HRH3ALDH1A1TSHRTAAR1LMNA
SCHEMBL20096075 0.76 LOXL2 (0.47) HRH3MAOBCA2MAOAGAA
SCHEMBL17157484 0.76 PTPRC (0.38) MAOBCYP1A2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10654852-B2 Antibiotics and methods of using same THE BROAD INSTITUTE, INC. (US) 2020-05-19 — — US disclosed
US-20190240203-A1 NOVEL ANTIBIOTICS AND METHODS OF USING SAME THE BROAD INSTITUTE, INC. (US) 2019-08-08 — — US disclosed
WO-2018075871-A1 NOVEL ANTIBIOTICS AND METHODS OF USING SAME THE BROAD INSTITUTE, INC. (US) 2018-04-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240203-A1 NOVEL ANTIBIOTICS AND METHODS OF USING SAME NRDC, TLR6, PEPD HRH3 2176/4885ALDH1A1 2254/4885TSHR 4145/4885
US-10654852-B2 Antibiotics and methods of using same NRDC, PEPD, TREH HRH3 3013/4885ALDH1A1 1694/4885TSHR 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback